Introduction

An overview of a pilot study on reduced-dose systemic fibrinolysis in massive pulmonary embolism, presenting new treatment insights and challenges encountered in dosing strategies. The speaker discusses the observational nature of the study conducted on 37 patients and its implications for patient care.